Survivin the Shuckin and Jivin
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GCEH first time trading over the 200 day MA in 3 yrs on the weekly. Should be a fun one over the coming months.
CYIO yep, I'll take em!
TSOI News
Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment
Date : 05/01/2018 @ 9:00AM
Source : InvestorsHub NewsWire
Stock : Therapeutic Solutions International, Inc. (PC) (TSOI)
Quote : 0.0058 0.0002 (3.57%) @ 10:09AM
Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment
Tweet
Print
Alert
Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial
with Pan Am Cancer Treatment Centers
Company Aims to Leverage Transfer Factor Pulsed Autologous Dendritic Cells on StemVacs Platform with
Patented Augmenter of Cancer Immunotherapy NanoStilbene
Oceanside, CA -- May 01, 2018 -- InvestorsHub NewsWire -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced today signing of an agreement with the Pan Am Cancer Treatment Center covering production and clinical implementation of its patent pending StemVacs Platform in combination with our Patented immunological adjuvant NanoStilbene.
StemVacs is generated using dendritic cell progenitors isolated from patients, which are activated by a proprietary process which has previously been demonstrated to endow dendritic cells with the ability to produce "natural cytokines", which kill cancer cells. NanoStilbene, a nanoparticle formulation of pterostilbene is covered for use in cancer immunotherapy under the Company's issued U.S. Patent No.: 9,682,047. Pterostilbene is the active ingredient in the Company's patented ProJuvenol product.
StemVacs is also subject of a filed Investigational New Drug Application (IND #17448) with the U.S. FDA. The IND seeks to establish safety and immune response of cancer, targeting a new personalized dendritic cell vaccine.
The Pan Am Cancer Treatment Center is a premier clinical research and treatment facility located in Tijuana, Mexico, which has been offering dendritic cell therapy for treatment of cancer patients. The current collaboration will leverage existing cellular therapy manufacturing expertise to develop and clinically apply, transfer factor pulsed autologous dendritic cells on the StemVacs Platform to patients.
"Having previously treated 10 patients with StemVacs in a proof-of-concept trial in collaboration with the Pan Am Cancer Treatment Center, we are very excited to expand the number of patients receiving this investigational immunotherapeutic approach" said Timothy Dixon, President and Chief Executive Officer of TSOI. "Under Compassionate Use and Right to Try, we are able to offer this fee-for-service treatment not available anywhere else in the world and very pleased to do so and even more pleased that every patient treated will also be adding NanoStilbene to their personalized treatment protocol"
"We are eager to offer this multi-protocol cancer immunotherapy to our patients, many of which who do not have any other treatment options available," said Dr. Javier Lopez, Chief Executive Officer of the Pan American Cancer Treatment Center. "By working with internationally renowned experts, such as the Scientific Advisory Board of Therapeutic Solutions International, we will strive to provide the most advanced immunotherapy for our patients."
"StemVacs is an immuno-oncology cellular therapy that programs the immune system to selectively attack malignant cells expressing the protein CTCFL, which acts as a "Master Orchestrator" of numerous genes needed for cancer to be cancer. Specifically, CTCFL is known to induce genes associated with cancer spreading, cancer mutating, and cancer becoming resistant to conventional therapies" said Thomas E Ichim, Ph.D., Board Member of TSOI. "Recent studies have found an association between CTCFL and cancer stem cells, suggesting the possibility that StemVacs actively destroys the "root" of the tumor, thus potentially increasing the probability of efficacy. I am particularly excited about the combination with NanoStilbene, whose active ingredient has previously been reported to possess activity against breast cancer and prostate cancer, the two cancers that we are actively treating."
About Therapeutic Solutions International, Inc.
The Company's corporate website is www.therapeuticsolutionsint.com. Our new products can be viewed on www.projuvenol.com and products can be ordered at www.youcanordernow.com.
These Supplement products have not been evaluated by the United States Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any diseases.
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our SEC filings. To the extent that statements in this press release are not strictly historical, including statements as to product launch timing, revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future collaboration agreements, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
CONTACT INFORMATION
Therapeutic Solutions International, Inc.
ir@tsoimail.com
Pan Am Cancer Treatment Center contact information:
Telephone: (619) 735-9581
Diego Rivera #2339 suite 108
Zona Rio, Tijuana B.C. 22010
www.cancerimmunotherapy.mx
info@cancerimmunotherapy.mx
Great analysis Midas! I think it’s spot on. It’s rare when you get this perfect storm scenario in the otc. Techs, fundamentals, filings, + possible news confirmation backed by a legit company with legit products and probable buyout scenario on the horizon. Don’t get me wrong, there will be ups and downs as is healthy in any run but those who endure may very well see this trading at the $s range with patience. IMHO
CELZ 8-K out
Current Report Filing (8-k)
Date : 04/27/2018 @ 5:29PM
Source : Edgar (US Regulatory)
Stock : Creative Medical Technology Holdings, Inc. (QB) (CELZ)
Quote : 0.0242 0.002 (9.01%) @ 4:00PM
Current Report Filing (8-k)
Print
Alert
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 26, 2018
Creative Medical Technology Holdings, Inc.
(Exact name of registrant as specified in its charter)
Nevada 000-53500 87-0622284
(State or other jurisdiction of
incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
2017 W Peoria Avenue, Phoenix, AZ 85029
(Address of principal executive offices)
Registrant’s telephone number, including area code: (602) 680-7439
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 3.02 Unregistered Sales of Equity Securities.
From April 20, 2018 through April 27, 2018, we issued an aggregate of 13,566,753 shares upon the conversions of outstanding notes and 28,548,513 shares upon the cashless exercise of outstanding warrants. These conversions were made pursuant to the exemption provided by Section 3(a)(9) of the Securities Act of 1933. As a result of these issuances, we have outstanding 641,502,996 shares of common stock as of April 27, 2018.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Creative Medical Technology Holdings, Inc.
Date: April 27, 2018 By: /s/ Donald Dickerson
Donald Dickerson, CFO
CELZ what a Beast! Great call my friend.
CELZ Yessir, and chart showing still in its early infancy stage of long term reversal. Very nice!
QSIM 74,103 Vol .001 x .0011
GCEH nice way to start the day.
Thx for pm
No ability to reply being a non subscriber but well noted and much appreciated, and yes I was “lucky”. Feel free to delete this non stock specific post.
Thx again bud!
Not just “looking strong” it is strong. Watch were this goes. Gonna be epic!! Watch or ride....
Someone slowly loading this on the downlow. I smell a run brewing. Radar it! Imo
Pipe dreamers abound. Make no mistake about it, this pos is headed for r/s, and the pos ceo is headed for prison...
SRMX providing cyber Monday sales for the last 4 months....
Aug 1 gap finally filled, see if this POS can turn around now or will they drive it to trips...
They go to their registered agent who is a required go-between to the S.O.S of the state they are incorporated (listed) in.
Like trying to staple water to a tree. Fricken B.S. whats going on here...
Thanks for sharing QMJ, much appreciated!
I would say a gagged TA is problem #1 for this co.. That's step one of developing trust amongst your shareholders. Instead we sit here and guess and speculate while SURPRISE!!! More share hit the market. This will never reach its true potential until they ungag the TA. And they will never ungag the TA until they are operating on the "up and up". This HUGE technology should have ZERO problems obtaining suitable, shareholder friendly financing. Bottom line, need to clean house and get the crooks out... and btw yes I'm a stockholder but that's just the way it is period...GLTA
Absolutely, these jackwagons have really effed this play up. Should be over .10 easily by now. Hopefully they can get out of their own way and SOON. Disgraceful happenings thus far...
was briefly anyway.
Bid / Ask spread much better
Very nice start!
Partnership with Microsoft and Freescale!
Tri Cascade will introduce the latest smart energy efficiency technologies faster than competitors due to its strategic partnership with Microsoft and Freescale. Tri Cascade will also have access to its partners superior marketing data and marketing vendors.
SMRX short volume report.
http://otcshortreport.com/index.php?index=SRMX
Big upswing in naked short volume from Aug 2nd-11th. Guess this round of conversion played right in their favor. The boys need to clean all this b.s. Up so we can trade without the conversion cloud overhead. Huge potential to be realized here if they don't eff it up! Imo of course
Less than a mil and a half volume. Massive you say? laughable
It was bound to happen. Chart traders seen the big red hammer candle on Thursday that triggered sells for them then the "never hold through weekend crowd" cashed out on Friday. Nevertheless, it was a healthy pullback and created great opportunities to add for those of us who KNOW what we own and KNOW where it's going. Not going to happen overnight but I'm pretty confident we are riding a future nasdaq stock here. Lots of focus on telecom right now and rightly so, but I'm telling you, this whole IoT thing is going to be massive with literally ENDLESS possibilities. We've only seen the tip of the iceburg of what's coming here. IMO of course $$$$$$
SRMX, gotta love how she's trading especially considering it's still flying WAY below the radar! We have a gem here folks, hold em tight!
$ELED fanpage GROWING like MySpace accounts!!!?? facebook.com/groups/1719749… $CHRO $AFOM $ASTI $BVTK $S $DBMM $DOLV $USRM $ICNB $OWCP $MMEX $MMHC $MRIB $TRTC
Just home from gym to see the .03 close, SRMX flexing and about to explode!
LMAO!
AHHH Sookie sookie, I love the look of them .03ssss Bring on .05s
May see .03s in next five minutes at this rate GOOOOO
Moving nicely now
Ok you have my attention. Thanks
That's the problem with these losers, they're insistent on creating as many bagholders as they can on the way down, so when it does drop to 002s and the next run begins, they know that the .04 buyers are gonna likely hold till break even as well as the .03 buyers etc. etc. which ensures they have staggered and manageable resistance on the way up. Spineless scavengers with empty claims of bottom, double bottom, triple bottom, triple lindy bottom, volumeless accumulation, and pipe dreams of millionaires loading for the looming $3 run lmao. These clowns ARE what kills the otc markets. Taking out liquidity by the post. Fake PR's and all, they know no no mercy just as long as they bank and get out Scott free. I hear the SEC really likes those manufactured PR's.....pump on ladies, you're leader has moved on, you're mods have moved on, and you're bagholders have woke up and stopped parroting your talking points. The gig is up. I know I know GO ELED!!!!! Triple bottom reversal underway!!!!!
Can $ELED run like $OWCP 003- $3?ABSOLUTELY NOT. FAILED PUMP, NO INTEREST ?????????? $AMLH $ASTI $AFOM $S $DBMM $DOLV $USRM $ICNB $OWCP $MMEX $MMHC $MRIB $CHRO $CBIS
LOL!! Already regretting your mistake. Gonna have to chase now to get back in!
FEE FAI FOE FUM, told ya long ago this play is done...